Covidien Seals X-Ray Contrast Agent Deal

 

November 19, 2007

November 19, 2007 – Covidien Imaging Solutions, a subsidiary of Covidien Ltd., signed a multi-year deal to supply X-ray contrast imaging agents to customers of MedAssets Supply Chain Systems, a St. Louis-based group purchasing organization, as part of Covidien's plan to broaden its distribution channels for its imaging agents.

Covidien will provide a range of products used to aid in the diagnosis of disease, including X-ray contrast agents, sodium chloride injection, USP 0.9 percent in Ultraject-prefilled syringes and MD-Gastroview (diatrizoate meglumine and diatrizoate sodium solution, USP). Covidien will also supply its full portfolio of contrast media injectors to MedAssets’ customers in accordance with a separate agreement signed earlier this year.

For more information: www.covidien.com and www.medassets.com